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Abstract
Background: Nutritional Risk Screening 2002 is recommended as a screening tool to
identify patients at risk of undernutrition for all patients in hospitals by the Eur-
opean Society of Clinical Nutrition and Metabolism. Nutritional risk is associated
with increased morbidity and mortality in patients, and it is common among patients
on haemodialysis. Factors associated with nutritional risk that could facilitate the
screening/diagnostic procedures are warranted.
Objectives: Identification of factors that are associated with nutritional risk in pa-
tients with end‐stage renal disease treated with haemodialysis.
Design and Participants: Single‐centre, cross‐sectional study in patients receiving
haemodialysis (n = 53) were screened for nutritional risk using Nutritional Risk
Screening 2002. Associations were made with data on dietary intake by 24‐h dietary
recall, and measurement of body composition, anthropometric measurements and
biochemical variables.
Results: Nutritional risk was common among patients on haemodialysis (26%), and
was associated with low energy and protein intake, and low pre‐albumin con-
centrations also after adjustments for age and sex. Nutritional risk was neither
associated with diabetes nor duration of dialysis treatment.
Conclusion: Measurement of pre‐albumin and dietary assessment using a 24‐h
dietary recall can support the identification of patients receiving haemodialysis at
nutritional risk.
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INTRODUCTION
Chronic kidney disease affects about 11%–13% of the total po-
pulation (Hill et al., 2016) and can eventually progress to kidney
failure requiring replacement therapy which affects about 5256
patients in Norway (The Norwegian Renal Registry, 2018). Of
these, about 1572 are treated with haemodialysis (HD). Kidney
failure is associated with profound changes in nutrient metabolism
and high rates of protein‐energy wasting and other nutritional
disturbances (Carrero et al., 2018; Fouque et al., 2008).
LITERATURE REVIEW
One method to identify patients who are undernourished or at risk
of becoming undernourished is the use of a screening tool for this
purpose, such as Malnutrition Universal Screening Tool (MUST), Mini
Nutritional Assessment (MNA) and Nutritional Risk Screening 2002
(NRS2002) (Cederholm et al., 2017). NRS2002 is recommended to be
used in hospitals by the European Society of Clinical Nutrition and
Metabolism (Cederholm et al., 2017; Kondrup et al., 2003). The aim
of NRS2002 is ‘to predict the probability of a better or worse out-
come due to nutritional factors, and whether nutritional treatment is
likely to influence this’ (Kondrup et al., 2003). NRS2002 uses factors
such as weight loss, reduced food intake and low body mass index
(BMI), disease severity and age for the identification of nutritional
risk. In Norway, all patients admitted to hospitals are scheduled to
undergo nutritional risk screening (Guttormsen, 2009). About 30% of
all hospitalised patients are at nutritional risk (Tangvik et al., 2015),
which is associated with increased risk of mortality and morbidity,
reduced quality of life, disability and prolonged hospital stay (Tangvik
et al., 2014). Of note, it is important to distinguish nutritional risk
screening from nutritional assessment. Nutritional assessment
should be performed in all patients identified as being at risk by
nutritional risk screening (Cederholm et al., 2017). Assessment of
nutritional status is a more complex procedure, and should include,
among others, information on anthropometry, body composition,
biochemical markers, dietary intake and requirements. Predefined
assessment tools exist, such as Subjective Global Assessment (SGA)
(Jeejeebhoy et al., 2015).
Within the NRS2002 screening procedures, especially the iden-
tification of reduced food intake is difficult in clinical practice, as pa-
tients do not recognise their food intake or do not remember this and
health personal often lack time or competence to judge whether food
intake is sufficient or not (Eide et al., 2015). One option for estimating
food intake in patients is a 24‐h dietary recall, which can give, if done
according to standardised procedures (Blanton et al., 2006) and ideally
repeated several times (Nutrition Research Council, 1981), sufficient
information on dietary intake of patients (Bingham et al., 1994).
In addition to weight and height, other measures of anthro-
pometry and body composition can give additional information about
the nutritional status. Among these, waist circumference, mid‐upper
arm circumference (MUAC) and body composition have been proven
useful in the assessment of nutritional status, with waist cir-
cumference closely related to overweight and obesity and associated
risks, and MUAC related to both under‐ and overnutrition (Pischon
et al., 2008; Rodrigues et al., 2017; Schaap et al., 2018).
Also, biochemical markers, mostly albumin and pre‐albumin con-
centrations, have been used to characterise nutritional status in pa-
tients receiving HD. Albumin concentrations have been shown to be
associated to nutritional status in some studies (Tan et al., 2016), but
not in all (Yang et al., 2020), and low albumin concentrations are
related to increased mortality in this patient group (Dierkes
et al., 2000). Albumin is, however, strongly influenced by inflammation
which limits the use to measure nutritional status (Pifer et al., 2002;
Takata et al., 2010). In contrast to albumin, pre‐albumin is not routi-
nely measured in many hospitals, but may work as a nutritional
marker in patients receiving HD (Chertow et al., 2000, 2005; Rambod
et al., 2008), although it is also affected by inflammation. It has,
however, not been linked to nutritional risk in these patients.
As it is known that nutritional risk is a problem in patients re-
ceiving HD, the aim of the study was to identify factors that are
associated with nutritional risk and that may facilitate the identifi-
cation and thus treatment of nutritional risk.
PATIENTS AND METHODS
This is a cross‐sectional study in patients with kidney failure treated
with HD at Haukeland University Hospital, Bergen, Norway. Patients
were eligible if clinically stable with HD for at least 3 months, aged
older than 18 years and capable of understanding Norwegian or
English. Patients were excluded if they had an expected living time of
<6 months.
All patients were screened by NRS2002. The initial screening
consists of four questions, and if one is answered with yes, the proce-
dure is continued to the main screening which consists of a point
scoring system regarding the nutrition status and severity of the dis-
ease. These are separately graded with a score from 0 to 3. Patients get
an additional age point if older than 70 years (Kondrup et al., 2003). A
patient is at nutritional risk if the total score is >3 points.
Food intake was estimated by a single 24‐h dietary recall con-
ducted by a trained interviewer using the multiple pass method
(Blanton et al., 2006). Other data collected than food and drink
consumption were food preparations methods, brand names and
ingredients used in mixed meals. Data were analysed using the online
tool Kostholdsplanleggeren.no which is based on the Norwegian food
composition tables. Low energy intake was defined as ≤25 kcal/kg
body weight and low protein intake as ≤0.80 g/kg body weight
(Fouque et al., 2008). For these calculations, measured body weight
after dialysis was used with no further adjustments.
Anthropometric measurements included weight and height,
waist circumference and MUAC. For these measurements, a portable
weight (Seca 877) and stadiometer (Seca model 217) was used and a
nonelastic, flexible tape (SECA), using standard procedures. From
weight and height, BMI was calculated.
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For the biochemical measurements, one blood sample per pa-
tient was taken before dialysis and usually after the weekend. Al-
bumin, C‐reactive protein (CRP), haemoglobin and lipids were
measured at the Central Laboratory at Haukeland University Hos-
pital using standard automated methods (details provided at www.
analyseoversikten.no). Pre‐albumin was measured using a nephelo-
metric method (BN‐II method; Siemens Healthineers Global). Dialysis
quality was expressed as Kt/V, information on residual function and
comorbidities (diabetes mellitus, hypertension) were derived from
the electronic patients' records.
For all data analyses conducted, IBM SPSS Statistics Software
version 25 (IBM Corp., released 2017, IBM SPSS Statistics for Win-
dows; IBM Corp.) was used. A comparison between those at nutri-
tional risk and those not at nutritional risk was made by Wilcoxon
tests or χ2 tests, followed by logistic regression analyses with NR/no‐
NR as a binary outcome for those variables that had p < 0.10 in the
Wilcoxon's test. Age and sex were always included in the logistic
regression. Prealbumin was additionally adjusted for CRP. To receive
meaningful estimates from the logistic regression analysis, the unit
for energy intake was transformed to 100 kcal instead of 1 kcal, and
the unit for pre‐albumin was transformed to g/dL instead of g/L.
The study has been approved by the regional ethics committee
for the Health Trust of Western Norway. All patients received oral
and written information about the study and gave their written in-
formed consent.
RESULTS
This analysis includes 53 patients out of our total population of 101
potentially eligible patients on HD, 74% men (n = 39) and 26% women
(n = 14), with an average age of 62 years. The average time on dialysis
was 691 days (1.89 years). Diabetic or hypertensive nephropathy was
the most common cause of kidney disease (42%), and both diabetes and
hypertension were common comorbidities (40% and 83%, respectively).
Energy intake was 1363 kcal/day in women and 1709 kcal/day in
men, and protein intake was 54 and 68 g/day, respectively. Low energy
intake (<25 kcal/kg BW) was observed in 58% of patients and low pro-
tein intake (<0.8 g/kgBW) was observed in 30% of patients, and 56%
had lower intake than 1.0 g/kgBW. Protein and energy intake were
strongly correlated (r=0.83; p<0.001). The average concentration of C‐
reactive protein (CRP) was <5mg/L, however, 10 patients had CRP le-
vels exceeding 15mg/L. Median albumin concentration was 41 g/L and
median prealbumin was 0.34 g/L. Other data from the anthropometric,
biochemical, clinical and dietary assessment are provided in Table 1.
Nutritional risk using NRS2002 was recognised in 14 patients
(10 men and 4 women, p < 0.05). Patients with nutritional risk were
older, had lower energy and protein intake and lower pre‐albumin
values (Table 2).
The logistic regression analysis showed an association of energy
intake, protein intake and pre‐albumin with nutritional risk, after con-
trolling for sex and age (Table 3). The RR for pre‐albumin was 0.33 (95%
confidence interval, 0.14–0.80) per g/dl increase of pre‐albumin and was
substantially attenuated to 0.90 after further adjustment for CRP
(Table 3).
DISCUSSION
This cross‐sectional study shows that nutritional risk is common among
patients with kidney failure receiving HD. This is alarming as nutritional
risk is associated with increased morbidity and mortality. Indeed, clin-
ical nutrition screening scores, among them NRS2002, predicted all‐
cause mortality better than biochemical variables (Dai et al., 2017;
Fiedler et al., 2009). Several other studies have found similar or even
higher rates of nutritional risk in this patient group, either by using
NRS2002 (Tan et al., 2016), or other assessment tools like SGA or
malnutrition inflammation score (MIS) (Fiedler, 2009; Dai, 2017), thus
supporting our findings. However, despite these high rates, there is a
lack of standard nutritional counselling and nutritional treatment in
patients with kidney disease in many countries (Sabbatini et al., 2019).
In the present study, we measured several anthropometric and
biochemical variables that have been associated with nutritional risk
in previous studies. In addition, we measured dietary intake by a
standardised 24‐h dietary recall. After adjusting for age and sex, only
energy and protein intake and pre‐albumin concentrations were
significantly associated with nutritional risk.
The screening for nutritional risk is nowadays routinely done in
many hospitals, however, several challenges remain, including the as-
sessment of food intake. Food intake is difficult to measure in an ob-
jective way, and ideally the assessment covers several days, including
dialysis and non‐dialysis days (Stark et al., 2011). Due to the limited
availability of dietitians in hospitals, data on food intake are often es-
timated in non‐standardised ways and thus of low quality (Mowe
et al., 2008; Phillips, 2015; Thoresen et al., 2008). Ideally, food intake is
measured by frequent standardised 24‐h dietary recalls, which could
also identify changes in dietary intake over time (Ikizler, 2020).
In the present study, patients at nutritional risk had indeed low
energy and protein intake, which was, independently from age and
sex, associated with nutritional risk. An increase in energy intake of
100 kcal/day was associated with a 12% lower risk for nutritional
risk. This amount is, for example, equivalent to one slice of whole‐
grain bread or a glass of milk. This result shows that it is important to
monitor the energy intake in patients receiving HD and encourage
sufficient energy intake. This is also important in light that there is a
strong correlation between energy and protein intake, thus it will be
likely that those who are not meeting their energy intakes will also
have low protein intakes. This will lead to a catabolic situation with
the loss of muscle mass and fat mass, and eventually lead to sarco-
penia or protein‐energy wasting (Hara et al., 2018; Moorthi &
Avin, 2017). Indeed, low protein intake was associated with a higher
risk of nutritional risk. In general, patients on HD have difficulties
meeting their protein requirement, due to lack of appetite, or dietary
restrictions especially on phosphorus (Bossola et al., 2005; Ikizler
et al., 2020; Stark et al., 2011). Additionally, patients receiving HD
frequently have restrictions on potassium, sodium and fluids, which
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TABLE 1 Characteristics of the study population
Total (n = 53) Female (n = 14) Male (n = 39)
General characteristics
Age, years 62 (48–75) 60 (49–75) 62 (47–77)
Time on dialysis, days 691 (431–1389) 452 (320–1123) 828 (492–1537)
BMI, kg/m2 24 (20–27) 22 (21–28) 25 (21–27)
Clinical data
Kt/Va 1.20 (0.92, 1.50) 1.70 (0.95, 1.90) 1.2 (0.90, 1.40)
Diabetes mellitus 21 (40%) 6 (43%) 15 (39%)
Hypertension 44 (83%) 12 (86%) 32 (82%)
Cause of CKD
–Diabetes or hypertension 22 (42%) 6 (43%) 16 (41%)
–Glomerular disease 6 (11%) 2 (14%) 4 (10%)
–Polyscystic kidney disease 5 (9%) 1 (7%) 4 (10%)
–Neoplastic disease 4 (8%) 1 (7%) 3 (8%)
–Other defined causes 10 (19%) 3 (21%) 7 (18%)
–Unknown 6 (11%) 1 (7%) 5 (13%)
Anthropometric data
Weight, kga 69.8 (61.4–79.7) 64.5 (53.8–70.0) 72.8 (63.2–81.7)
Height, m 1.71 (1.64–1.77) 1.60 (1.56–1.66) 1.73 (1.69–1.80)
MUAC, cm 29.0 (26.2–31.8) 27.0 (25.1–32.1) 29.0 (26.3–31.7)
WC, cm 94.5 (83.8–102.3) 84.7 (79.4–98.6) 95.0 (86.5–104.3)
Biochemical data
Haemoglobin, g/dl 11.1 (10.3–12.1) 10.1 (9.9–11.9) 11.2 (10.4–12.2)
Pre‐albumin, g/L 0.340 (0.280–0.400) 0.375 (0.315–0.423) 0.330 (0.260–0.400)
Albumin, g/L 41 (38–43) 40 (38–43) 41 (39–43)
CRP, mg/L 3 (1–9) 3 (0–14) 3 (1–9)
Total cholesterol, mmol/L 3.4 (2.7–4.3) 3.9 (2.7–4.5) 3.2 (2.7–4.1)
Dietary intake
Energy, kcal 1594 (1154–1956) 1363 (973–1582) 1709 (1315–2462)
Energy, kcal/kg BW 22 (17–29) 21 (15–28) 24 (17–30)
Protein, g/day 66 (47–84) 54 (40–75) 68 (54–94)
Protein, g/kg BW 0.93 (0.72–1.24) 0.95 (0.35–1.24) 0.93 (0.74–1.26)
Protein, E% 16 (14–19) 17 (15–19) 16 (14–19)
Fat, g 67 (41‐86) 55 (31‐67) 71 (50‐90)
Fat, E% 38 (30–43) 37 (27–42) 38 (30–44)
Carbohydrate, g 187 (134–254) 145 (126–175) 201 (148–262)
Carbohydrate, E% 48 (41–53) 47 (38–57) 48 (41–52)
Fibre, g 14 (10–21) 13 (10–14) 16 (9–24)
Note: Continuous data are given as median with interquartile range in parentheses, and frequencies are provided as n and % in parentheses.
Abbreviations: CRP, C‐reactive protein; E%, energy percent; kg BW, kilogram per body weight; MUAC, mid‐upper arm circumference; WC, waist
circumference.
aWeight is given as weight after dialysis. Measurements of two patients were missing for pre‐albumin. Measurements of three patients were missing for
energy and protein intake. Kt/V information was available in 36 patients.
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makes it even more challenging to meet the dietary recommenda-
tions and demonstrate the importance of dietary counselling.
The majority of the patients in our cohort had low concentra-
tions of CRP, indicating limited inflammation. This is a prerequisite
that serum albumin and pre‐albumin concentrations, which are ne-
gative acute phase reactants, can be used for the diagnosis of
malnutrition (Dellière & Cynober, 2017). While albumin was not
associated to nutritional risk, pre‐albumin was significantly asso-
ciated to nutritional risk, and each increase of 0.1 g/L (1 g/dl) was
associated to a 10% reduction of nutritional risk, after adjustment
for CRP. This is even more remarkable as almost no patient had very
low pre‐albumin concentrations (<0.1 g/L). Pre‐albumin has been
suggested by several authors as a marker for nutritional risk, as-
suming that the serum concentrations are responsive to dietary in-
take below the requirements (Devoto et al., 2006; Zhang
et al., 2017). Pre‐albumin was also a predictor of mortality and
hospitalisation in a prospective study with patients receiving HD and
follow up for 3 years (Fiedler, 2009). Thus, the results support in-
cluding pre‐albumin measurements into the routine biochemical as-
sessment of patients on HD, to ease the identification of
nutritional risk.
Our study has several strengths and limitations. First, this is a
cross‐sectional study without patient follow‐up. Thus, we can only
speculate on the impact of nutritional risk for further prognosis. It
should be also mentioned that due to the limited sample size, the
study should be regarded as a pilot study that should be confirmed in
larger studies. Also, the dietary assessment was limited to a single
24‐h dietary recall. Ideally, either a dietary record for several days,
including dialysis and non‐dialysis days (Burrowes et al., 2003), or
multiple 24‐h dietary recalls should be used for dietary assessment
to increase the reliability and validity of the data. Among the
TABLE 2 Biochemical and anthropometric measurements and dietary intake in dialysis patients with and without NR
NR, Yes NR, No p value
Female/male 4/10 10/29 0.046
Age, years 58 (46, 80) 62 (49, 75) 0.739
Time on dialysis 603 (389, 1655) 828 (461, 1325) 0.716
Diabetes, % 6/14 (43%) 15/39 (38%) 0.773
Weight, kg 68.6 (54.8, 80.2) 70.1 (62.8, 80.2) 0.215
BMI, kg/m2 23 (20, 28) 24 (22, 27) 0.572
MUAC, cm 27.0 (24.8, 30.4) 29.0 (26.3, 32.0) 0.140
WC, cm 92.5 (77.2, 108.9) 94.5 (85.0, 101.3) 0.716
Energy, kcal 1186 (898, 1747) 1623 (1378, 2433) 0.045
Energy, kcal/kg BW 18 (14, 29) 24 (19, 30) 0.083
Protein, g/day 52.4 (35.9, 69.3) 68.4 (54.1, 92.5) 0.043
Protein, g/kg BW 0.74 (0.57, 1.14) 0.99 (0.81, 1.26) 0.075
Protein, E% 15 (13, 20) 16 (14, 19) 0.368
Albumin, g/L 39.5 (36.5, 43) 42.0 (39.0, 43.0) 0.123
Pre‐albumin, g/dl 0.310 (0.220, 0.330) 0.385 (0.307, 0.403) 0.013
Haemoglobin, g/dl 10.7 (10.2, 11.2) 11.2 (10.3, 12.5) 0.332
CRP, mg/L 3 (0, 21) 3 (1, 7) 0.976
Note: Data are presented as median and IQR. Nutritional risk was diagnosed according to NRS2002. Bold values stastistically significant at p < 0.05.
Abbreviations: CRP, C‐reactive protein; E%, energy percent; IQR, interquartile range; kg BW, kilogram per body weight; MUAC, mid‐upper arm
circumference; NR, nutritional risk; NRS2002, Nutritional Risk Screening 2002; PAL, physical activity level; WC, waist circumference.
TABLE 3 Logistic regression for risk factors for NRS risk,
controlled for age and sex
RR 95% CI
MUAC, cm 0.88 0.74–1.05
Energy, 100 kcal 0.88 0.78–0.99
Energy, kcal/kg BW 0.94 0.86–1.02
Protein, g/day 0.97 0.94–1.00
Protein, g/kg BW 0.20 0.03–1.28
Protein, E% 0.92 0.78–1.09
Pre‐albumin, g/dla 0.90 0.82–0.98
Note: PAL calculated by dividing energy intake with resting
metabolic rate.
Abbreviations: CI, confidence interval; CRP, C‐reactive protein; E
%, energy percent; kg BW, per kilogram body weight; NRS, nutritional risk
screening; PAL, physical activity level; RR, relative risk.
aAdjusted for age, sex and CRP.
NUTRITIONAL RISK AND HAEMODIALYSIS | 5
strengths of the study, it is worth mentioning the standardised and
comprehensive assessment of nutritional status, nutritional risk and
biochemical measurements.
IMPLICATIONS FOR CLINICAL PRACTICE
Nutritional risk was a common finding in patients receiving HD and
was observed in one of four patients. Nutritional risk screening
should use a validated screening tool such as NRS2002, and should
be repeated weekly, or at least monthly (Guttormsen, 2009). Patients
at nutritional risk should receive a more thorough nutritional as-
sessment and a nutritional treatment plan.
Our study showed that both assessment of energy and protein
intake and measurement of pre‐albumin are useful additions to the
nutritional risk screening. Therefore, regular nutritional risk screening,
followed by assessment of energy and protein intake and measurement
of pre‐albumin, is recommended in patients receiving HD.
CONCLUSION
In conclusion, a dietary assessment by a single 24‐h dietary recall can
identify patients at nutritional risk who may benefit from nutritional
therapy. Dietary intake was overall insufficient in this population, and
more attention should be paid to dietary counselling and treatment.
Pre‐albumin was strongly associated with nutritional risk in this cohort
and should be included in the routine biochemical assessment.
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